Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Stem Cell Collect, LLC was a healthcare services company that entered into a strategic partnership with NeoStem (now Lisata Therapeutics) in 2010 to expand adult stem cell collection infrastructure in the United States. Under the agreement, the company acquired the rights to establish and operate multiple collection facilities utilizing NeoStem's proprietary protocols for the harvesting and long-term cryopreservation of adult stem cells. The business model was centered on autologous stem cell banking, providing individuals with the opportunity to store their own healthy cells for potential future use in regenerative therapies. The company's operations were part of a broader effort to commercialize stem cell storage services before the industry shifted focus toward direct therapeutic development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Stem Cell Collect.